Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 3
1992 4
1993 7
1994 10
1995 12
1996 18
1997 12
1998 17
1999 25
2000 23
2001 28
2002 16
2003 17
2004 11
2005 12
2006 10
2007 5
2008 11
2009 16
2010 13
2011 10
2012 7
2013 8
2014 6
2015 5
2016 6
2017 5
2018 7
2019 4
2020 9
2021 10
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Results by year

Filters applied: . Clear all
Page 1
Herpes Labialis: An Update.
Leung AKC, Barankin B. Leung AKC, et al. Recent Pat Inflamm Allergy Drug Discov. 2017;11(2):107-113. doi: 10.2174/1872213X11666171003151717. Recent Pat Inflamm Allergy Drug Discov. 2017. PMID: 28971780 Review.
Topical antiviral agents such as 5% acyclovir cream/ointment (Zovirax) hydrocortisone (Xerese), 1% penciclovir (Denavir) cream, and 50 mg Buccal Adhesive Tablet (ABT-50 mg) can also be used for episodic treatment of herpes labialis. ...
Topical antiviral agents such as 5% acyclovir cream/ointment (Zovirax) hydrocortisone (Xerese), 1% penciclovir (Denavir) cream, and 5 …
Famciclovir/penciclovir.
Sacks SL, Wilson B. Sacks SL, et al. Adv Exp Med Biol. 1999;458:135-47. doi: 10.1007/978-1-4615-4743-3_13. Adv Exp Med Biol. 1999. PMID: 10549386 Review. No abstract available.
Penciclovir cream--improved topical treatment for herpes simplex infections.
Schmid-Wendtner MH, Korting HC. Schmid-Wendtner MH, et al. Skin Pharmacol Physiol. 2004 Sep-Oct;17(5):214-8. doi: 10.1159/000080214. Skin Pharmacol Physiol. 2004. PMID: 15452407 Review.
As a conclusion, different studies are available that have shown that it is possible to reduce viral replication and hasten lesion resolution with 1% penciclovir treatment beyond the prodromal phase of the HSV infection. Comparing data of topical treatment with acyclovir a …
As a conclusion, different studies are available that have shown that it is possible to reduce viral replication and hasten lesion resolutio …
Antiviral Drugs Against Alphaherpesvirus.
Shiraki K. Shiraki K. Adv Exp Med Biol. 2018;1045:103-122. doi: 10.1007/978-981-10-7230-7_6. Adv Exp Med Biol. 2018. PMID: 29896665 Review.
The discovery of acyclovir and penciclovir has led to the development of a successful systemic therapy for treating herpes simplex virus infection and varicella-zoster virus infection, and the orally available prodrugs, valacyclovir and famciclovir, have improved antiviral …
The discovery of acyclovir and penciclovir has led to the development of a successful systemic therapy for treating herpes simplex vi …
New antiviral agents.
Abdel-Haq N, Chearskul P, Al-Tatari H, Asmar B. Abdel-Haq N, et al. Indian J Pediatr. 2006 Apr;73(4):313-21. doi: 10.1007/BF02825826. Indian J Pediatr. 2006. PMID: 16816493 Review.
This review focuses on newer systemic and topical antiviral agents that are used in treatment of herpes viruses including herpes simplex type-1 (HSV-1) and type-2 (HSV-2), varicella-zoster virus (VZV) and cytomegalovirus CMV) as well as the human papilloma virus (HPV). Included i …
This review focuses on newer systemic and topical antiviral agents that are used in treatment of herpes viruses including herpes simplex typ …
Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
Sarisky RT, Bacon TH, Boon RJ, Duffy KE, Esser KM, Leary J, Locke LA, Nguyen TT, Quail MR, Saltzman R. Sarisky RT, et al. Arch Virol. 2003 Sep;148(9):1757-69. doi: 10.1007/s00705-003-0124-7. Arch Virol. 2003. PMID: 14505088 Clinical Trial.
Asusceptibility testing program was established to determine the prevalence of resistance to penciclovir among herpes simplex virus isolates collected from patients participating in 11 world-wide clinical trials involving penciclovir (topical or intravenous formulat …
Asusceptibility testing program was established to determine the prevalence of resistance to penciclovir among herpes simplex virus i …
Pilot Study of the Safety and Tolerability of a Subconjunctival Penciclovir Implant in Cats Experimentally Infected with Herpesvirus.
Covert JC, Thomasy SM, Kado-Fong H, Kon LN, Kass PH, Reilly CM, Lappin MR, Margulies BJ, Maggs DJ. Covert JC, et al. J Ocul Pharmacol Ther. 2019 Jan/Feb;35(1):38-49. doi: 10.1089/jop.2018.0043. Epub 2018 Dec 18. J Ocul Pharmacol Ther. 2019. PMID: 30562134
Plasma penciclovir concentrations remained below 10 ng/mL. Cats with higher tear penciclovir concentrations at inoculation and/or time of peak disease had fewer corneal ulcers than cats in which tear penciclovir concentrations were inconsistent, low, or unrec …
Plasma penciclovir concentrations remained below 10 ng/mL. Cats with higher tear penciclovir concentrations at inoculation and …
Inspection on the Mechanism of SARS-CoV-2 Inhibition by Penciclovir: A Molecular Dynamic Study.
Giannetti M, Mazzuca C, Ripani G, Palleschi A. Giannetti M, et al. Molecules. 2022 Dec 26;28(1):191. doi: 10.3390/molecules28010191. Molecules. 2022. PMID: 36615385 Free PMC article.
Here we propose a molecular dynamic study to provide insight into the inhibition mechanism of Penciclovir, a nucleotide analog on the RNA-dependent RNA polymerase enzyme. ...
Here we propose a molecular dynamic study to provide insight into the inhibition mechanism of Penciclovir, a nucleotide analog on the …
337 results